EVGN

#4738
Evogene Ltd. - Ordinary Shares
0.7 1 USD
0.00%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.71
0.71
Jahresspanne
0.66
2.42
Tagesänderung
0.00%
Monatliche Änderung
-6.58%
6 month change
-30.39%
Jahresänderung
-36.04%
Vorheriger Schlusskurs
0.7 1
Open
0.7 1
Tief
0.7 1
High
0.7 1
Volumen
1
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 6.19 M
  • Employee 52
  • Founded 1999
  • CEO Ofer Haviv
  • Website www.evogene.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Evogene Ltd. - Ordinary Shares

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

Nachrichten